NCT01901575View on ClinicalTrials.gov

Remifentanil Intravenous Patient Controlled Analgesia (IVPCA) for Ablation of Idiopathic Ventricular Tachycardia

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Tachycardia, Ventricular
Interventions
DRUG

Remifentanil

Patients with established PVC's , sedated with remifentanil IVPCA per study protocol

Trial Locations (1)

10016

NYU Langone Medical Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT01901575 - Remifentanil Intravenous Patient Controlled Analgesia (IVPCA) for Ablation of Idiopathic Ventricular Tachycardia | Biotech Hunter | Biotech Hunter